Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: Results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial

Circulation

Volumn 105, Issue 20, 2002, Pages 2361-2366

  Januzzi Jr , James L ^a   Snapinn, Steven M ^b   DiBattiste, Peter M ^b   Jang, Ik Kyung ^a   Theroux, Pierre ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Kidney; Myocardial infarction; Platelets

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TIROFIBAN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CREATININE CLEARANCE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE;

ACUTE DISEASE; AGED; CORONARY ARTERIOSCLEROSIS; CREATININE; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEPARIN; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE; MALE; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; TYROSINE;

EID: 0037150156     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000016359.94919.16     Document Type: Article

References (22)

1. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
2. Clinical predictors of in-hospital prognosis in unstable angina: ECLA 3: The ECLA collaborative group
3. Acute myocardial infarction in patients with end-stage renal disease
4. Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the cooperative cardiovascular project
5. Renal disease as a risk factor for cardiovascular disease
6. Current status of prevention, diagnosis, and management of coronary artery disease in patients with kidney failure
7. Coronary artery disease in patients with renal failure
8. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction
9. Medical and revascularization management in acute coronary syndrome in renal patients
10. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
11. Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance
12. Thrombolysis in Myocardial Infarction (TIMI) trial, phase 1: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge
13. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?
14. Coronary artery bypass grafting in patients with dialysis-dependent renal failure
15. Coronary artery bypass grafting in 105 patients with hemodialysis-dependent renal failure
16. Impaired high-shear-stress-induced platelet aggregation in patients with chronic renal failure undergoing haemodialysis
17. Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease
18. Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia
19. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors
20. Prognostic value of ST segment depression in acute coronary syndromes: Insights from PARAGON-A applied to GUSTO-IIb: PARAGON-A and GUSTO IIb Investigators: Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network
21. Assessment of renal function and progression of disease
22. Renal function in the elderly